Literature DB >> 11435452

Genetic and pharmacological analysis of prostanoid receptor function.

S Narumiya1, G A FitzGerald.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11435452      PMCID： PMC209349          DOI： 10.1172/JCI13455

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  49 in total

1.  Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation.

Authors:  B Rocca; A L Loeb; J F Strauss; R Vezza; A Habib; H Li; G A FitzGerald
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene.

Authors:  M Unoki; S Furuta; Y Onouchi; O Watanabe; S Doi; H Fujiwara; A Miyatake; K Fujita; M Tamari; Y Nakamura
Journal:  Hum Genet       Date:  2000-04       Impact factor: 4.132

3.  Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro.

Authors:  X Li; Y Okada; C C Pilbeam; J A Lorenzo; C R Kennedy; R M Breyer; L G Raisz
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

4.  Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide.

Authors:  Y Sakuma; K Tanaka; M Suda; A Yasoda; K Natsui; I Tanaka; F Ushikubi; S Narumiya; E Segi; Y Sugimoto; A Ichikawa; K Nakao
Journal:  J Bone Miner Res       Date:  2000-02       Impact factor: 6.741

5.  Intrinsic prostacyclin contributes to exudation induced by bradykinin or carrageenin: a study on the paw edema induced in IP-receptor-deficient mice.

Authors:  A Ueno; H Naraba; Y Ikeda; F Ushikubi; T Murata; S Narumiya; S Oh-ishi
Journal:  Life Sci       Date:  2000-02-11       Impact factor: 5.037

6.  Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.

Authors:  K Watanabe; T Kawamori; S Nakatsugi; T Ohta; S Ohuchida; H Yamamoto; T Maruyama; K Kondo; F Ushikubi; S Narumiya; T Sugimura; K Wakabayashi
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

7.  Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation.

Authors:  B F McAdam; I A Mardini; A Habib; A Burke; J A Lawson; S Kapoor; G A FitzGerald
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

8.  Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors.

Authors:  Y Zhang; Y Guan; A Schneider; S Brandon; R M Breyer; M D Breyer
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

9.  Prostaglandin D2 as a mediator of allergic asthma.

Authors:  T Matsuoka; M Hirata; H Tanaka; Y Takahashi; T Murata; K Kabashima; Y Sugimoto; T Kobayashi; F Ushikubi; Y Aze; N Eguchi; Y Urade; N Yoshida; K Kimura; A Mizoguchi; Y Honda; H Nagai; S Narumiya
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

10.  Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei.

Authors:  S Narumiya; K Ohno; M Fukushima; M Fujiwara
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030
View more
  119 in total

Review 1.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.

Authors:  S L Tilley; T M Coffman; B H Koller
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.

Authors:  C N Serhan; E Oliw
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

3.  Virus self-improvement through inflammation: no pain, no gain.

Authors:  Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  The expanding network of redox signaling: new observations, complexities, and perspectives.

Authors:  Roy J Soberman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 5.  Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics.

Authors:  Charles N Serhan; Bruce Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

Review 6.  The organization and consequences of eicosanoid signaling.

Authors:  Roy J Soberman; Peter Christmas
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

7.  Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cells.

Authors:  Tariq Shah; Ioannis Stasinopoulos; Flonne Wildes; Samata Kakkad; Dmitri Artemov; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2011-09-22       Impact factor: 4.044

8.  Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice.

Authors:  Abdullah Shafique Ahmad; Muzamil Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Age (Dordr)       Date:  2010-03-05

9.  Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.

Authors:  L Chastine Bell-Parikh; Tomomi Ide; John A Lawson; Peter McNamara; Muredach Reilly; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  Modeling of eicosanoid fluxes reveals functional coupling between cyclooxygenases and terminal synthases.

Authors:  Yasuyuki Kihara; Shakti Gupta; Mano R Maurya; Aaron Armando; Ishita Shah; Oswald Quehenberger; Christopher K Glass; Edward A Dennis; Shankar Subramaniam
Journal:  Biophys J       Date:  2014-02-18       Impact factor: 4.033
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.